FI20051255A0 - Vaccine suitable for the next influenza A pandemic - Google Patents

Vaccine suitable for the next influenza A pandemic

Info

Publication number
FI20051255A0
FI20051255A0 FI20051255A FI20051255A FI20051255A0 FI 20051255 A0 FI20051255 A0 FI 20051255A0 FI 20051255 A FI20051255 A FI 20051255A FI 20051255 A FI20051255 A FI 20051255A FI 20051255 A0 FI20051255 A0 FI 20051255A0
Authority
FI
Finland
Prior art keywords
pandemic
vaccine suitable
next influenza
influenza
vaccine
Prior art date
Application number
FI20051255A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Pekka Untamo Heino
Original Assignee
Pekka Untamo Heino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pekka Untamo Heino filed Critical Pekka Untamo Heino
Priority to FI20051255A priority Critical patent/FI20051255A0/en
Publication of FI20051255A0 publication Critical patent/FI20051255A0/en
Priority to PCT/FI2006/000402 priority patent/WO2007065967A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20051255A 2005-12-05 2005-12-05 Vaccine suitable for the next influenza A pandemic FI20051255A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20051255A FI20051255A0 (en) 2005-12-05 2005-12-05 Vaccine suitable for the next influenza A pandemic
PCT/FI2006/000402 WO2007065967A1 (en) 2005-12-05 2006-12-04 A vaccine suitable for use against the next influenza a pandemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20051255A FI20051255A0 (en) 2005-12-05 2005-12-05 Vaccine suitable for the next influenza A pandemic

Publications (1)

Publication Number Publication Date
FI20051255A0 true FI20051255A0 (en) 2005-12-05

Family

ID=35510625

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20051255A FI20051255A0 (en) 2005-12-05 2005-12-05 Vaccine suitable for the next influenza A pandemic

Country Status (2)

Country Link
FI (1) FI20051255A0 (en)
WO (1) WO2007065967A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1030449A (en) * 1972-09-25 1978-05-02 Edwin D. Kilbourne Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US4552758A (en) * 1983-12-20 1985-11-12 St. Jude Children's Research Hospital Human use of avian-human reassortants as vaccines for influenza A virus
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
JP5600375B2 (en) * 2004-03-09 2014-10-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Influenza virus vaccine

Also Published As

Publication number Publication date
WO2007065967A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
EP1819357A4 (en) Vaccines for the rapid response to pandemic avian influenza
NO20054608D0 (en) Influenza vaccine
WO2007051036A8 (en) Influenza combinatorial antigen vaccine
IL196024A0 (en) Influenza vaccine
DK2043682T3 (en) INFLUENZA VACCINE
DK2069503T3 (en) PAPAYAMOSAIKVIRUS-BASED VACCINES AGAINST INFLUENZA
BRPI0716536A2 (en) production of influenza virus vaccines without the use of eggs
DK1986678T3 (en) SOLUTION AID FOR ORAL PEPTIDE ADMINISTRATION, INCLUDING A BIGUANIDE
HK1129838A1 (en) Adjuvanted influenza vaccines including cytokine-inducing agents
EP1906998A4 (en) Peptide-based influenza vaccine formulation
DK1968631T3 (en) VACCINE
DK3984528T3 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB
ATE531358T1 (en) SELF-SUPPORTING AQUEOUS PHARMACEUTICAL COMPOSITIONS
EP1917040A4 (en) Polyvalent vaccine
FR2901478B1 (en) MULTIMICROPARTICULATED ORAL PHARMACEUTICAL FORM WITH PROLONGED RELEASE
PL1942933T3 (en) Canine influenza vaccines
DK1871181T3 (en) Supplements for HIV patients
EP2091960A4 (en) Peptide vaccine for influenza virus
ZA200809056B (en) Influenza virus vaccine
DK2918286T3 (en) A PHARMACEUTICAL FORMULATION
EP2097103A4 (en) Influenza vaccine formulation
DK1877549T3 (en) HIV vaccine
FI20051255A0 (en) Vaccine suitable for the next influenza A pandemic
ATE530164T1 (en) AQUEOUS PHARMACEUTICAL PREPARATION
ZA200900062B (en) Influenza vaccine

Legal Events

Date Code Title Description
FD Application lapsed